Analysis and Commentary STEVEN GROSSMAN 9/18/20 Analysis and Commentary STEVEN GROSSMAN 9/18/20 Public Trust in the US FDA Read More Analysis and Commentary STEVEN GROSSMAN 5/15/20 Analysis and Commentary STEVEN GROSSMAN 5/15/20 How H.R. 6800 Might Impact the FDA Read More Advocacy at a Glance STEVEN GROSSMAN 5/15/20 Advocacy at a Glance STEVEN GROSSMAN 5/15/20 Virtual Mark-ups: Prerequisite for Movement of Appropriations Bills Read More Advocacy at a Glance STEVEN GROSSMAN 5/8/20 Advocacy at a Glance STEVEN GROSSMAN 5/8/20 House and Senate Appropriations Committees Still Committed, Off to a Slow Start Read More Advocacy at a Glance STEVEN GROSSMAN 5/1/20 Advocacy at a Glance STEVEN GROSSMAN 5/1/20 Senate Returns May 4; Appropriations Activities Planned and Rules for Remote Voting Are Prominent Read More Analysis and Commentary STEVEN GROSSMAN 4/17/20 Analysis and Commentary STEVEN GROSSMAN 4/17/20 The COVID-19 Pandemic and Maintenance of a Continued Safe Food Supply Read More Advocacy at a Glance STEVEN GROSSMAN 4/17/20 Advocacy at a Glance STEVEN GROSSMAN 4/17/20 Congress Out Until at Least May 4; Not Clear How Work Will Be Done Read More Analysis and Commentary STEVEN GROSSMAN 4/3/20 Analysis and Commentary STEVEN GROSSMAN 4/3/20 Advocating for a Responsibility-based "Ask" Read More Advocacy at a Glance STEVEN GROSSMAN 4/3/20 Advocacy at a Glance STEVEN GROSSMAN 4/3/20 Alliance Submits House/Senate Testimony on FY 21 Appropriations for FDA Read More Analysis and Commentary STEVEN GROSSMAN 3/27/20 Analysis and Commentary STEVEN GROSSMAN 3/27/20 Coronavirus, Pandemic Preparedness, and Beyond Read More Advocacy at a Glance STEVEN GROSSMAN 3/20/20 Advocacy at a Glance STEVEN GROSSMAN 3/20/20 Alliance Completes Hill Day with Conference Calls and Much Enthusiasm on Both Sides Read More Analysis and Commentary STEVEN GROSSMAN 3/13/20 Analysis and Commentary STEVEN GROSSMAN 3/13/20 "Cures," Coronavirus, NDD, and Other Issues for FY 21 Read More Analysis and Commentary STEVEN GROSSMAN 3/5/20 Analysis and Commentary STEVEN GROSSMAN 3/5/20 Additional funding for FDA; more Qs and As Read More Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Alliance Hill Day On March 18; You Don’t Have to Be an FDA Expert to Participate Read More
Analysis and Commentary STEVEN GROSSMAN 9/18/20 Analysis and Commentary STEVEN GROSSMAN 9/18/20 Public Trust in the US FDA Read More
Analysis and Commentary STEVEN GROSSMAN 5/15/20 Analysis and Commentary STEVEN GROSSMAN 5/15/20 How H.R. 6800 Might Impact the FDA Read More
Advocacy at a Glance STEVEN GROSSMAN 5/15/20 Advocacy at a Glance STEVEN GROSSMAN 5/15/20 Virtual Mark-ups: Prerequisite for Movement of Appropriations Bills Read More
Advocacy at a Glance STEVEN GROSSMAN 5/8/20 Advocacy at a Glance STEVEN GROSSMAN 5/8/20 House and Senate Appropriations Committees Still Committed, Off to a Slow Start Read More
Advocacy at a Glance STEVEN GROSSMAN 5/1/20 Advocacy at a Glance STEVEN GROSSMAN 5/1/20 Senate Returns May 4; Appropriations Activities Planned and Rules for Remote Voting Are Prominent Read More
Analysis and Commentary STEVEN GROSSMAN 4/17/20 Analysis and Commentary STEVEN GROSSMAN 4/17/20 The COVID-19 Pandemic and Maintenance of a Continued Safe Food Supply Read More
Advocacy at a Glance STEVEN GROSSMAN 4/17/20 Advocacy at a Glance STEVEN GROSSMAN 4/17/20 Congress Out Until at Least May 4; Not Clear How Work Will Be Done Read More
Analysis and Commentary STEVEN GROSSMAN 4/3/20 Analysis and Commentary STEVEN GROSSMAN 4/3/20 Advocating for a Responsibility-based "Ask" Read More
Advocacy at a Glance STEVEN GROSSMAN 4/3/20 Advocacy at a Glance STEVEN GROSSMAN 4/3/20 Alliance Submits House/Senate Testimony on FY 21 Appropriations for FDA Read More
Analysis and Commentary STEVEN GROSSMAN 3/27/20 Analysis and Commentary STEVEN GROSSMAN 3/27/20 Coronavirus, Pandemic Preparedness, and Beyond Read More
Advocacy at a Glance STEVEN GROSSMAN 3/20/20 Advocacy at a Glance STEVEN GROSSMAN 3/20/20 Alliance Completes Hill Day with Conference Calls and Much Enthusiasm on Both Sides Read More
Analysis and Commentary STEVEN GROSSMAN 3/13/20 Analysis and Commentary STEVEN GROSSMAN 3/13/20 "Cures," Coronavirus, NDD, and Other Issues for FY 21 Read More
Analysis and Commentary STEVEN GROSSMAN 3/5/20 Analysis and Commentary STEVEN GROSSMAN 3/5/20 Additional funding for FDA; more Qs and As Read More
Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Alliance Hill Day On March 18; You Don’t Have to Be an FDA Expert to Participate Read More
